Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 06, 2026
Upperton Pharma Solutions has introduced a new brand identity at CPHI Milan, reflecting its expansion into a contract development and manufacturing organization offering services from formulation development through commercial production.
read more
Tuesday, October 06, 2026
Agilent Technologies is adding laboratory space in Boulder, Colorado, to develop and scale up manufacturing technologies for oligonucleotide therapeutics, with an initial focus on enzymatic ligation.
read more
SK pharmteco plans to invest more than $200 million over five years to expand U.S. development and manufacturing capacity for small-molecule active pharmaceutical ingredients and peptides.
read more
Lonza and Asimov have formed a collaboration to develop manufacturing approaches for lentiviral vectors used in emerging in vivo therapies. The companies will combine Asimov’s cell-line technologies with Lonza’s process development, scale-up, ...
read more
Thursday, October 01, 2026
Sartorius and MAbSilico have launched a service to assess whether experimental therapeutic proteins are suitable for further development and manufacturing. Their non-exclusive collaboration combines MAbSilico’s computational analysis with Sartorius’ ...
read more
Thursday, October 01, 2026
BioDuro has appointed Greg Makara senior vice president of lead discovery chemistry, putting him in charge of expanding computational chemistry, AI and lead discovery work within its early-stage drug discovery services.
read more
Thursday, October 01, 2026
Lonza is expanding a preclinical program in Bend, Oregon, to study aseptic spray drying as a way to formulate biologic medicines, including products that require high doses delivered by injection under the skin.
read more
Thursday, October 01, 2026
SPI Pharma and Colorcon have formed a global partnership to distribute and develop oral solid-dose products. Under the agreement, Colorcon will serve as SPI Pharma’s distribution and innovation partner for its drug delivery systems portfolio.
read more
Thursday, October 01, 2026
Ensera has launched an alliance network with five companies involved in device platforms and injectable drug manufacturing. The Dublin-based contract development and manufacturing organization said the network is intended to help pharmaceutical ...
read more
Thursday, October 01, 2026
Symbiosis Pharmaceutical Services has appointed three employees to its commercial team as the Scottish contract manufacturer expands its business development efforts in Asia-Pacific, the Middle East and Southern Europe.
read more
Thursday, October 01, 2026
53Biologics is investing more than €2 million to add freeze-drying equipment at its manufacturing site in Boecillo, Spain. The expansion will allow the contract developer and manufacturer to offer an additional fill-and-finish step for biologic ...
read more
Wednesday, September 30, 2026
Piramal Pharma Solutions and nonprofit generic drug manufacturer NP2 expect to complete the development phase of their injectable cyclophosphamide product in October. Development is taking place at Piramal’s sterile injectable facility in Lexington, ...
read more
Wednesday, September 30, 2026
OnDosis has selected Adare Pharma Solutions to provide development and manufacturing services for Imfocy, its lead U.S. program for attention-deficit/hyperactivity disorder.
read more
Tuesday, September 29, 2026
Serán Bioscience has secured a growth investment led by Biospring Partners to expand its pharmaceutical development and manufacturing operations in Bend, Oregon. Existing investors Vivo Capital and Bain Capital Life Sciences, along with Serán ...
read more
Tuesday, September 29, 2026
Ontario is providing C$1.75 million through its Life Sciences Scale-Up Fund to support upgrades at Piramal Pharma Solutions’ drug substance facility in Aurora. Piramal plans to invest C$5.31 million in the site project.
read more